An Official Website of the United States Government
Company Information:
Name:
BIOUSIAN BIOSYSTEMS, INC. (BBI)
Address:
51 FOLLEN RD
LEXINGTON, MA 02421-
LEXINGTON, MA 02421-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Novel Glycosylated Delta Opioid Receptor Agonists for Chronic Inflammatory Pain
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Kimberley S. Gannon
Award Amount:
$199,556.00
Abstract:
DESCRIPTION (provided by applicant): Biousian Biosystems Inc. (BBI) intends to develop novel, glycosylated, deltorphin-based peptides as orally available drugs for the treatment of chronic inflammatory pain. By targeting a 4-selective mechanism, it is anti
cipated that compounds with improved… More
Novel Glycosylated Delta Opioid Receptor Agonists for Chronic Inflammatory Pain
Award Year / Program / Phase:
2011 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Mark S. Kleven – 215-910-2261
Award Amount:
$992,331.00
Abstract:
DESCRIPTION (provided by applicant): Traditionally, Mu opioid receptor (MOR) agonists have not been given as first line treatments for neuropathic pain due to their significant adverse side effects. Biousian Biosystems Inc, (BBI) is developing novel glycosylated peptide-based delta opioid receptor… More